Recombinant Novel Coronavirus (COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Novel Coronavirus (COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine, covering 2023-06-08 to 2023-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine [Phase 3]